Kashani I A, Shakibi J G, Siassi B
Jpn Heart J. 1980 Jul;21(4):485-90. doi: 10.1536/ihj.21.485.
The effects of verapamil, a slow channel blocker and a potent antiarrhythmic drug, on retrograde V-A conduction were investigated following diagnostic cardiac catheterization in 12 children premedicated with lytic cocktail. Surface EKG, intra-atrial and His bundle electrograms, as well as right ventricular pacing with use of extra stimulus technique were obtained before and after a single intravenous dose of verapamil (0.15 mg/Kg, max 5 mg). Verapamil prolonged the AH interval in 9/12 and abolished or prolonged the retrograde V-A conduction whenever present (abolition in 5/12 and prolongation in 1/12). The duration of retrograde V-A conduction exceeded the antegrade conduction time in all. It is concluded that verapamil abolishes retrograde V-A conduction whenever present and this phenomenon may further explain the antiarrhythmic effects of the drug on retrograde conduction dependent (reentrant) arrhythmias.
在12名预先使用溶细胞合剂进行预处理的儿童接受诊断性心导管插入术后,研究了慢通道阻滞剂及强效抗心律失常药物维拉帕米对逆行性室房传导的影响。在单次静脉注射维拉帕米(0.15mg/kg,最大剂量5mg)之前和之后,记录体表心电图、心房内电图和希氏束电图,以及采用额外刺激技术进行右心室起搏。维拉帕米使12例中的9例AH间期延长,并且只要存在逆行性室房传导,便会使其消除或延长(12例中的5例消除,12例中的1例延长)。所有病例中逆行性室房传导的持续时间均超过了顺行性传导时间。得出的结论是,维拉帕米只要存在逆行性室房传导便会将其消除,并且这一现象可能进一步解释了该药物对依赖逆行传导(折返性)心律失常的抗心律失常作用。